Influenza infections in children are problematic not only for the immediate symptoms they cause but also for their potentially large contribution to influenza infections in other age groups. Since 2008, the Advisory Committee on Immunization Practices has recommended that all children at least 6 months old be vaccinated annually against influenza. By historical standards, vaccination coverage in children in the United States is high, with nearly 60% of children younger than age 18 years and 76% of children aged 6 to 23 months receiving an influenza vaccine in the 2016-2017 season. 1 Vaccination coverage in children has also expanded in the United Kingdom, where indirect benefits on other age groups have been observed. 2 The recent expansion of vaccination coverage has coincided with increased attention to the vexing problem of why the vaccine is not more effective, and especially to scattered observations that the vaccine may be less effective in frequent recipients. 3 Although many analyses of repeated vaccination included children in their study populations, they were underpowered to examine effects by age, and their statistical conclusions were inevitably heavily influenced by adults. Young children and adults can respond to vaccines differently, however, partly because they share different exposure histories. 
